Breast Ref Applicant: Abbott-Arkansas Medical Sciences (2013)
No involved investigator sites defined.
We are evaluating whether detection of a tumor-specific N-linked glycosylation known as B 1,6 branched N-glycan present on the glycoprotein periostin in breast cancer will be useful as a new biomarker for the detection of breast cancer in patient plasma and serum. We have completed an initial study using samples with known inavasive ductal breast carcinoma diagnosis and the results look very promising. Therefore, we would like to proceed with our analysis of this potential biomarker for breast cancer diagnosis by analyzing the blinded samples in breast reference set 1.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.